Dongkekangde Honored as a "Provincial Specialized, Sophisticated, Distinctive, and Innovative SME of Jiangsu Province for 2025"!

Recently, the Department of Industry and Information Technology of Jiangsu Province officially announced the "List of Provincial Specialized, Sophisticated, Distinctive, and Innovative SMEs of Jiangsu Province for 2025." Jiangsu Dongkekangde Pharmaceutical Co., Ltd. (hereinafter referred to as "Dongkekangde"), a wholly-owned subsidiary of Comer Pharmaceutical, has been successfully recognized for its deep cultivation and outstanding performance in the pharmaceutical R&D field!

01 Provincial Honor, Testament to Strength

"Specialized, Sophisticated, Distinctive, and Innovative" SMEs refer to small and medium-sized enterprises characterized by specialization, refinement, distinctiveness, and innovation. The recognition of such SMEs in Jiangsu Province serves as a crucial tool for cultivating high-quality enterprises. It imposes strict requirements on applicant companies in terms of economic performance, operational conditions, specialization, refinement, distinctiveness, and innovation capabilities. By setting clear and high standards, it guides the majority of SMEs to focus on their main business, strengthen their internal competencies, enhance innovation, achieve personalized development, and inject strong momentum into the economic transformation and upgrading of the province.

Since its establishment, Dongkekangde has adhered to an innovation-driven development strategy, establishing an efficient R&D system and technology platform. It has formed independent intellectual property rights and core technological advantages in the pharmaceutical R&D field. Dongkekangde remains committed to providing convenient and efficient one-stop services for its cooperative clients, covering the entire lifecycle of Marketing Authorization Holder (MAH) projects. This includes project Chemistry, Manufacturing, and Controls (CMC) development, supplier management and audits, Contract Manufacturing Organization (CMO) selection and audits, technology transfer, clinical audits, delegated production supervision, sales and usage management, traceability management, and pharmacovigilance management. Dongkekangde successfully obtained a Drug Manufacturing License (Category B) in September 2022.

02 Building on a New Starting Point, Striving for a New Journey

This recognition as a "Provincial Specialized, Sophisticated, Distinctive, and Innovative SME of Jiangsu Province" marks a new step for Dongkekangde on its development path towards specialization, refinement, distinctiveness, and innovation. It also represents full affirmation of the company's innovation capabilities, technological strength, and market position.

Dongkekangde will take this recognition as motivation to continuously enhance its own capacity building, further deepen technological innovation, and strive towards higher-level goals as a specialized, sophisticated, distinctive, and innovative enterprise. It aims to contribute more to promoting the high-quality development of Jiangsu Province's biomedical industry.